These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18355681)

  • 21. Lys3-bombesin conjugated to 99mTc-labelled gold nanoparticles for in vivo gastrin releasing peptide-receptor imaging.
    Mendoza-Sánchez AN; Ferro-Flores G; Ocampo-García BE; Morales-Avila E; de M Ramírez F; De León-Rodríguez LM; Santos-Cuevas CL; Medina LA; Rojas-Calderón EL; Camacho-López MA
    J Biomed Nanotechnol; 2010 Aug; 6(4):375-84. PubMed ID: 21323111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo evaluation of Alexa Fluor 680-bombesin[7-14]NH2 peptide conjugate, a high-affinity fluorescent probe with high selectivity for the gastrin-releasing peptide receptor.
    Ma L; Yu P; Veerendra B; Rold TL; Retzloff L; Prasanphanich A; Sieckman G; Hoffman TJ; Volkert WA; Smith CJ
    Mol Imaging; 2007; 6(3):171-80. PubMed ID: 17532883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7-14)NH2], in a prostate tumor xenografted mouse model.
    Lane SR; Nanda P; Rold TL; Sieckman GL; Figueroa SD; Hoffman TJ; Jurisson SS; Smith CJ
    Nucl Med Biol; 2010 Oct; 37(7):751-61. PubMed ID: 20870150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors.
    Okarvi SM; Al Jammaz I
    Nucl Med Biol; 2010 Apr; 37(3):277-88. PubMed ID: 20346867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New chelation strategy allows for quick and clean 99mTc-labeling of synthetic peptides.
    Blok D; Feitsma HI; Kooy YM; Welling MM; Ossendorp F; Vermeij P; Drijfhout JW
    Nucl Med Biol; 2004 Aug; 31(6):815-20. PubMed ID: 15246374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of 64Cu-labeled bifunctional chelate-bombesin conjugates.
    Ait-Mohand S; Fournier P; Dumulon-Perreault V; Kiefer GE; Jurek P; Ferreira CL; Bénard F; Guérin B
    Bioconjug Chem; 2011 Aug; 22(8):1729-35. PubMed ID: 21761921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receptor-binding, biodistribution, dosimetry, and micro-SPECT/CT imaging of 111In-[DTPA(1), Lys(3), Tyr(4)]-bombesin analog in human prostate tumor-bearing mice.
    Ho CL; Chen LC; Lee WC; Chiu SP; Hsu WC; Wu YH; Yeh CH; Stabin MG; Jan ML; Lin WJ; Lee TW; Chang CH
    Cancer Biother Radiopharm; 2009 Aug; 24(4):435-43. PubMed ID: 19694578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours.
    Abiraj K; Mansi R; Tamma ML; Forrer F; Cescato R; Reubi JC; Akyel KG; Maecke HR
    Chemistry; 2010 Feb; 16(7):2115-24. PubMed ID: 20066690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 99mTc(I)-postlabeled high affinity bombesin analogue as a potential tumor imaging agent.
    La Bella R; Garcia-Garayoa E; Bahler M; Bläuenstein P; Schibli R; Conrath P; Tourwé D; Schubiger PA
    Bioconjug Chem; 2002; 13(3):599-604. PubMed ID: 12009951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging.
    Nock B; Nikolopoulou A; Chiotellis E; Loudos G; Maintas D; Reubi JC; Maina T
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):247-58. PubMed ID: 12552343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and in vitro and in vivo evaluation of hypoxia-enhanced 111In-bombesin conjugates for prostate cancer imaging.
    Zhou Z; Wagh NK; Ogbomo SM; Shi W; Jia Y; Brusnahan SK; Garrison JC
    J Nucl Med; 2013 Sep; 54(9):1605-12. PubMed ID: 23896558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of functionalized coligands on the pharmacokinetics of 99mTcIII '4+1' mixed-ligand complexes conjugated to bombesin.
    Kunstler JU; Bergmann R; Gniazdowska E; Koźmiński P; Walther M; Pietzsch HJ
    J Inorg Biochem; 2011 Nov; 105(11):1383-90. PubMed ID: 21946438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors.
    Zhang H; Chen J; Waldherr C; Hinni K; Waser B; Reubi JC; Maecke HR
    Cancer Res; 2004 Sep; 64(18):6707-15. PubMed ID: 15374988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: a concise update.
    Smith CJ; Volkert WA; Hoffman TJ
    Nucl Med Biol; 2003 Nov; 30(8):861-8. PubMed ID: 14698790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc: a preclinical study.
    Nock BA; Nikolopoulou A; Galanis A; Cordopatis P; Waser B; Reubi JC; Maina T
    J Med Chem; 2005 Jan; 48(1):100-10. PubMed ID: 15634004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycation methods for bombesin analogs containing the (NalphaHis)Ac chelator for 99mTc(CO)3 radiolabeling.
    Brans L; Maes V; García-Garayoa E; Schweinsberg C; Daepp S; Bläuenstein P; Schubiger PA; Schibli R; Tourwé DA
    Chem Biol Drug Des; 2008 Dec; 72(6):496-506. PubMed ID: 19016795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
    Chen X; Park R; Hou Y; Tohme M; Shahinian AH; Bading JR; Conti PS
    J Nucl Med; 2004 Aug; 45(8):1390-7. PubMed ID: 15299066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer.
    Zhang X; Cai W; Cao F; Schreibmann E; Wu Y; Wu JC; Xing L; Chen X
    J Nucl Med; 2006 Mar; 47(3):492-501. PubMed ID: 16513619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, radiolabelling and biological characteristics of a bombesin peptide analog as a tumor imaging agent.
    Okarvi SM; al-Jammaz I
    Anticancer Res; 2003; 23(3B):2745-50. PubMed ID: 12894569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 99mTc-N2S2-Tat (49-57)-bombesin internalized in nuclei of prostate and breast cancer cells: kinetics, dosimetry and effect on cellular proliferation.
    Santos-Cuevas CL; Ferro-Flores G; Rojas-Calderón EL; García-Becerra R; Ordaz-Rosado D; Arteaga de Murphy C; Pedraza-López M
    Nucl Med Commun; 2011 Apr; 32(4):303-13. PubMed ID: 21304415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.